Actinium Pharmaceuticals, Inc. Skyrocketed
Tue, Mar 19, 2024 at 07:28 PM
Actinium Pharmaceuticals, Inc. (ATNM:NYSEMKT) shot up at $8.21, a gain of 25.5%. On Tue, Mar 19, 2024, ATNM:NYSEMKT touched a New 2-Week High of $8.21. The stock appeared on our News Catalysts scanner on Mon, Mar 11, 2024 at 08:28 AM in the 'MISCELLANEOUS' category. From Tue, Mar 05, 2024, the stock recorded 40.00% Up Days and 45.45% Green Days
About Actinium Pharmaceuticals, Inc. (ATNM:NYSEMKT)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of innovative-targeted therapies for patients with cancers lacking effective treatment options. The company's product portfolio includes Iomab-B and Actimab-A.
Top 10 Gainers:
- Ontrak Inc. (OTRK:NASDAQ), 131.58%
- Fusion Pharmaceuticals Inc. (FUSN:NASDAQ), 99.06%
- SCWorx Corp. (WORX:NASDAQ), 53.51%
- Sarcos Technology and Robotics Corporation (STRC:NASDAQ), 40.38%
- Enliven Therapeutics Inc Com (ELVN:NASDAQ), 38.77%
- Puyi Inc. (PUYI:NASDAQ), 33.93%
- BitFuFu Inc. (FUFU:NASDAQ), 32.35%
- Critical Metals Corp. (CRML:NASDAQ), 31.04%
- Vincerx Pharma Inc. (VINC:NASDAQ), 28.31%
- Actinium Pharmaceuticals, Inc. (ATNM:NYSEMKT), 25.54%